Suppr超能文献

响应DNA损伤而控制细胞周期的激酶:Chk1、Chk2和MK2。

Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

作者信息

Reinhardt H Christian, Yaffe Michael B

机构信息

David H Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Curr Opin Cell Biol. 2009 Apr;21(2):245-55. doi: 10.1016/j.ceb.2009.01.018. Epub 2009 Feb 21.

Abstract

In response to DNA damage eukaryotic cells activate cell cycle checkpoints -- complex kinase signaling networks that prevent further progression through the cell cycle. Parallel to implementing a cell cycle arrest, checkpoint signaling also mediates the recruitment of DNA repair pathways. If the extent of damage exceeds repair capacity, additional signaling cascades are activated to ensure elimination of these damaged cells. The DNA damage response has traditionally been divided into two major kinase branches. The ATM/Chk2 module is activated after DNA double strand breaks and the ATR/Chk1 pathway responds primarily to DNA single strand breaks or bulky lesions. Both pathways converge on Cdc25, a positive regulator of cell cycle progression, which is inhibited by Chk1-mediated or Chk2-mediated phosphorylation. Recently a third effector kinase complex consisting of p38MAPK and MK2 has emerged. This pathway is activated downstream of ATM and ATR in response to DNA damage. MK2 has been shown to share substrate homology with both Chk1 and Chk2. Here we will discuss recent advances in our understanding of the eukaryotic DNA damage response with emphasis on the Chk1, Chk2, and the newly emerged effector kinases p38MAPK and MK2.

摘要

作为对DNA损伤的反应,真核细胞会激活细胞周期检查点——一种复杂的激酶信号网络,可阻止细胞周期的进一步进程。在实施细胞周期停滞的同时,检查点信号还介导DNA修复途径的募集。如果损伤程度超过修复能力,会激活额外的信号级联反应以确保清除这些受损细胞。传统上,DNA损伤反应被分为两个主要的激酶分支。DNA双链断裂后,ATM/Chk2模块被激活,而ATR/Chk1途径主要对DNA单链断裂或大块损伤作出反应。两条途径都汇聚于Cdc25,这是一种细胞周期进程的正调控因子,它会被Chk1介导或Chk2介导的磷酸化所抑制。最近,一种由p38MAPK和MK2组成的第三种效应激酶复合物出现了。该途径在ATM和ATR下游因DNA损伤而被激活。已证明MK2与Chk1和Chk2都具有底物同源性。在这里,我们将讨论我们对真核生物DNA损伤反应理解的最新进展,重点是Chk1、Chk2以及新出现的效应激酶p38MAPK和MK2。

相似文献

引用本文的文献

10
Advances in synthetic lethality modalities for glioblastoma multiforme.多形性胶质母细胞瘤合成致死模式的进展。
Open Med (Wars). 2024 Jun 10;19(1):20240981. doi: 10.1515/med-2024-0981. eCollection 2024.

本文引用的文献

2
ATR: an essential regulator of genome integrity.ATR:基因组完整性的关键调节因子。
Nat Rev Mol Cell Biol. 2008 Aug;9(8):616-27. doi: 10.1038/nrm2450. Epub 2008 Jul 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验